| Literature DB >> 33445365 |
Lu Han1, Ya-Nan Hao1, Xing Wei1, Xu-Wei Chen1, Yang Shu1, Jian-Hua Wang1.
Abstract
A novel core-shell nanostructure, hollow copper sulfide nanosphere-doxorubicin (DOX)/graphene oxide (GO) (CuS-DOX/GO), is constructed for the purpose of controlled drug delivery and improved photothermo-chemotherapeutic effect. The CuS-DOX/GO nanocomposite is configured by employing dual photothermal agents, where the core, hollow CuS nanoparticle, acts as delivery-carrier for doxorubicin, and the shell, PEGylated GO nanosheet, prohibits leakage of the drug. DOX can be efficiently loaded onto the hollow CuS nanoparticles, and its subsequent release from CuS-DOX/GO nanocomposite is triggered in a pH- and near-infrared light-dependent manner. Moreover, integration of the two photothermal agents significantly improves the photothermal performance of this system. Ultimately, the combination of phototherapy and chemotherapy based on this system results in a much higher HeLa cell killing efficacy with respect to that for a single chemotherapy mode, as demonstrated by in vitro cytotoxicity tests.Entities:
Keywords: cancer therapy; controlled drug delivery; copper sulfide; graphene oxide; photothermal therapy
Year: 2017 PMID: 33445365 DOI: 10.1021/acsbiomaterials.7b00643
Source DB: PubMed Journal: ACS Biomater Sci Eng ISSN: 2373-9878